AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.39
0.39
Rango anual
0.39
45.75
Cambio diario
-99.02%
Variación mensual
-99.07%
Variación en los últimos 6 meses
-98.64%
Cambio anual
-97.84%
Cierres anteriores
40.4 2
Open
0.3 9
Mínimo
0.3 9
High
0.3 9
Volumen
121
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Noticias